FDA NDC Directory · JSON-LD · Markdown

Olanzapine

NDC 65862-656 · HUMAN PRESCRIPTION DRUG · TABLET, ORALLY DISINTEGRATING

Labeler / ManufacturerAurobindo Pharma Limited
Marketing categoryAbbreviated NDA (generic) · App ANDA203708
Dosage form / routeTABLET, ORALLY DISINTEGRATING · ORAL
Active ingredientsOLANZAPINE (5 mg/1)
Marketing started20140515
Package count1

External sources

Source: openFDA. Public-domain (CC0).